Cite
HARVARD Citation
Gerding, D. et al. (2018). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clinical infectious diseases. pp. 649-656. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gerding, D. et al. (2018). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clinical infectious diseases. pp. 649-656. [Online].